![Steven King](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Steven King
Chief Executive Officer at
MOSAIC IMMUNOENGINEERING, INC.
Net worth: 831 674 $ as of 31/05/2026
Profile
Steven W.
King was the founder of Avid Bioservices, Inc., founded in 2001, where the titles held included President, Chief Executive Officer & Director from 2001 to 2017.
Mr. King is the founder of Mosaic ImmunoEngineering, Inc., founded in 2020, holding the titles of President, CEO, CFO & Director since 2020.
Current jobs include President, Chief Executive Officer & Director at Mosaic ImmunoEngineering Development Co., Director at Oncotelic Therapeutics, Inc. since 2020, and Director at Oncotelic, Inc. Former jobs included President, Chief Executive Officer & Director at Avid Bioservices, Inc. from 2011 to 2017, Chief Executive Officer at Edgepoint, Inc., and Director at Patriot Scientific Corp.
in 2020.
Education includes undergraduate and graduate degrees from Texas Tech University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 31/03/2025 | 16,41,252 ( 22.66% ) | 635 165 $ | 31/05/2026 | |
| 12/04/2025 | 33,30,647 ( 0.75% ) | 196 508 $ | 31/05/2026 | |
| 21/08/2020 | 1,61,000 ( 25.56% ) | 2 $ | 31/08/2020 |
Steven King active positions
| Companies | Position | Start |
|---|---|---|
| ONCOTELIC THERAPEUTICS, INC. | Director/Board Member | 11/05/2020 |
| MOSAIC IMMUNOENGINEERING, INC. | Chief Executive Officer | 31/08/2020 |
Oncotelic, Inc.
 Oncotelic, Inc. BiotechnologyHealth Technology Develops RNA therapeutics and small molecule drugs targeting cancer and infectious diseases | Director/Board Member | - |
Mosaic ImmunoEngineering Development Co.
 Mosaic ImmunoEngineering Development Co. BiotechnologyHealth Technology Develops novel immunotherapies to treat and prevent cancer and infectious diseases | Chief Executive Officer | - |
Former positions of Steven King
| Companies | Position | End |
|---|---|---|
| AVID BIOSERVICES, INC. | Chief Executive Officer | 27/11/2017 |
Edgepoint, Inc. | Chief Executive Officer | - |
| PATRIOT SCIENTIFIC CORPORATION | Chief Executive Officer | - |
Avid Bioservices, Inc. /Old/
 Avid Bioservices, Inc. /Old/ Medical/Nursing ServicesHealth Services Provides highly specialized cell cultures for biotechnology testing | Founder | - |
Training of Steven King
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
29
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Avid Bioservices, Inc.
 Avid Bioservices, Inc. Pharmaceuticals: MajorHealth Technology Engages in the developing and manufacturing of biologics | Health Technology |
Patriot Scientific Corp.
 Patriot Scientific Corp. SemiconductorsElectronic Technology Develops microprocessors | Electronic Technology |
Oncotelic Therapeutics, Inc.
 Oncotelic Therapeutics, Inc. BiotechnologyHealth Technology Engages in developing novel small-molecule therapeutics to treat cancer and eye diseases | Health Technology |
Texas Tech University
 Texas Tech University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avid Bioservices, Inc. /Old/
Avid Bioservices, Inc. /Old/ Medical/Nursing ServicesHealth Services Provides highly specialized cell cultures for biotechnology testing | Health Services |
Edgepoint, Inc. | |
Oncotelic, Inc.
Oncotelic, Inc. BiotechnologyHealth Technology Develops RNA therapeutics and small molecule drugs targeting cancer and infectious diseases | Health Technology |
Mosaic ImmunoEngineering Development Co.
Mosaic ImmunoEngineering Development Co. BiotechnologyHealth Technology Develops novel immunotherapies to treat and prevent cancer and infectious diseases | Health Technology |
Mosaic ImmunoEngineering, Inc.
 Mosaic ImmunoEngineering, Inc. BiotechnologyHealth Technology Develops immunotherapy pharmaceuticals | Health Technology |
- Stock Market
- Insiders
- Steven King
